Please select the second broker

Author: Alan LittleDate: 2021-01-01

2U (TWOU) and Levi Strauss (LEVI) rise in midweek trading

Educational company 2U (TWOU) and clothing giant Levi Strauss (LEVI) were among those making gains on Wednesday, while AstraZeneca (AZN) fell despite winning approval for its vaccine.

2U, Inc. (TWOU) was one of the biggest movers on Wednesday, rising 7% in trading after Needham named the educational tech company as one of its top stock picks for next year.

Needham believes that 2U, which supplies a cloud-based SaaS platform to clients, has been a key beneficiary from the recent pivot to digital-based education.

2U has already seen its shares soar 76% for the year to date and Needham’s recommendation is unlikely to slow that momentum heading into the new year.

Its selection as top pick for 2021 saw TWOU advance a further 7.14% on the Nasdaq to $42.47.

Levi Strauss & Co Headquarters, California, USA

Levi Strauss (LEVI) also eased 1.84% higher in midweek after Guggenheim added $4 to a new $24 price target in a bullish note to clients.

“We are encouraged by the company’s offensive strategy, strong brand, experienced management team, and healthy financial position,” analysts at the firm said.

Those fundamentals should put LEVI in a strong position when it begins to shrug off COVID-19-related disruptions in the coming months.

Bullish coverage also helped Dynatrace (DT) to rise 3.77% on the New York Stock Exchange on Wednesday.

Analysts at BTIG set a buy rating for the software intelligence platform on what it perceives to be the potential for strong growth in core markets next year.

The ongoing digital transformation drive will enable Dynatrace to prosper in the application performance management market, according to BTIG, which also offered a $56 price target.

Finally, AstraZeneca (AZN) closed 0.82% lower on the London Stock Exchange, even though its coronavirus vaccine was approved in the UK in a move that will see a mass rollout begin in early January.


Scam Brokers, Broker Complaints

Are you aware of a scam broker or want to make a broker complaint?

We want our site users to find good brokers to trade through and to be warned off bad brokers. We encourage you to use our complaints tool to let us know about your experiences.

We have categorised the common complaints to make it easier for you and we have provided some guidance on what you may want to try before submitting a complaint, if our suggestions do not provide you with a resolution then by submitting a complaint, our team will attempt to take up your case with the relevant Broker and if needed, submit a formal report to the regulators.

We use the information you give us to decide if we want to continue to promote a broker on our site.

Your scam broker complaint not only helps you, it helps others and it helps us determine if we continue to support the broker.